Milvexian for the Prevention of Venous Thromboembolism
- 15 November 2021
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 385 (23), 2161-2172
- https://doi.org/10.1056/nejmoa2113194
Abstract
Factor XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism may be more effective and result in less bleeding than conventional anticoagulants. Additional data are needed regarding the efficacy and safety of milvexian, an oral factor XIa inhibitor.This publication has 13 references indexed in Scilit:
- Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF StudyJournal of the American Heart Association, 2020
- Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee ArthroplastyJAMA, 2020
- International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registriesAmerican Heart Journal, 2017
- Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism eventsBlood, 2017
- Factor XI Antisense Oligonucleotide for Prevention of Venous ThrombosisThe New England Journal of Medicine, 2015
- Model‐based dose finding under model uncertainty using general parametric modelsStatistics in Medicine, 2013
- Congenital Factor XI Deficiency: An UpdateSeminars in Thrombosis and Hemostasis, 2013
- Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosisThrombosis and Haemostasis, 2011
- A dose‐ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplastyJournal of Thrombosis and Haemostasis, 2010
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patientsJournal of Thrombosis and Haemostasis, 2009